Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (151-160 of 384) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyFrances A Shepherd, Janet Dancey, Rodryg Ramlau, et al.
Clinical Lung Cancer|August 10, 2016
A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung CancerKit Man Wong, Keyue Ding, Suzanne Li, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancerAnthony Brade, Andrea Bezjak, Robert MacRae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of CancerFrances A Shepherd, Giuseppe Giaccone, Lesley Seymour, et al.
Clinical Lung Cancer|January 8, 2013
Factors influencing a specific pathologic diagnosis of non-small-cell lung carcinomaJeffrey A Sulpher, Scott P Owen, Henrique Hon, et al.
ESMO Open|March 30, 2020
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10Stacy Grieve, Keyue Ding, Jonathan Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trialsTimothy R Asmis, Keyue Ding, Lesley Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancerSimon J Crabb, Demetris Patsios, Eric Sauerbrei, et al.
Respiratory Medicine|September 30, 2021
Stratification and management of patients ineligible for lung cancer screeningReenika Aggarwal, Andrew Cl Lam, Jingyue Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2012
Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissueGord Fehringer, Geoffrey Liu, Melania Pintilie, et al.
Pageof 39

Showing results (151-160 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyFrances A Shepherd, Janet Dancey, Rodryg Ramlau, et al.
Clinical Lung Cancer|August 10, 2016
A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung CancerKit Man Wong, Keyue Ding, Suzanne Li, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancerAnthony Brade, Andrea Bezjak, Robert MacRae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of CancerFrances A Shepherd, Giuseppe Giaccone, Lesley Seymour, et al.
Clinical Lung Cancer|January 8, 2013
Factors influencing a specific pathologic diagnosis of non-small-cell lung carcinomaJeffrey A Sulpher, Scott P Owen, Henrique Hon, et al.
ESMO Open|March 30, 2020
Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of JBR.10Stacy Grieve, Keyue Ding, Jonathan Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trialsTimothy R Asmis, Keyue Ding, Lesley Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancerSimon J Crabb, Demetris Patsios, Eric Sauerbrei, et al.
Respiratory Medicine|September 30, 2021
Stratification and management of patients ineligible for lung cancer screeningReenika Aggarwal, Andrew Cl Lam, Jingyue Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2012
Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissueGord Fehringer, Geoffrey Liu, Melania Pintilie, et al.
Pageof 39